Silvia Scurati的动态

In the US, 7.7% of the population has been diagnosed with asthma. The #disease presents with different levels of #severity and is also classified into 5 different types: adult-onset asthma, exercise-induced bronchoconstriction, occupational asthma, allergic asthma, and non-allergic asthma. Although most Americans with #asthma are aware of their condition, the type of asthma they have and what #triggers it may often be unknown. With the help of the American College of Allergy, Asthma and Immunology (ACAAI) read on to understand the 5 different #types of asthma and how they are triggered. https://lnkd.in/eYrVk8ei

The EVEREST study published in the Journal of Asthma and Allergy, “Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry”, has shed light on the significant global disease burden faced by patients suffering from severe asthma, including those without access to biologic therapies, those who were eligible but did not receive these treatments, and T2-targeted biologic recipients. The findings underscore the urgent need for improved healthcare resource utilization, increased access to biologics, and ongoing research on new treatment options to address the unmet needs of patients with severe asthma. Read the full press release: https://lnkd.in/g93bnptj Read the full article here: https://lnkd.in/gXYdYMS3 #ResearchInRealLife #SevereAsthma #Asthma #Research

?? New Publication Alert! ?? Excited to share our latest review on ?? Real-world evidence of allergen immunotherapy (AIT) ??? Our research delves into the unique benefits of AIT, the only disease-modifying treatment for allergies, highlighting its long-term effectiveness and safety. Discover how real-world studies complement randomized controlled trials, providing valuable insights into AIT's impact on patients with allergic respiratory diseases. ???? Don't miss out on this comprehensive exploration of AIT's role in managing allergies and improving quality of life! ?? https://lnkd.in/duAuZJHJ @Buta Federica, Giovanni Paoletti, Maria Chiara Bragato, Mattia Giovannini, Giorgio Walter Canonica, Enrico Heffler Humanitas University Humanitas Research Hospital #Allergy #Immunotherapy #MedicalResearch #HealthcareInnovation #ClinicalStudies

The EVEREST study published in the Journal of Asthma and Allergy, “Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry”, has shed light on the significant global disease burden faced by patients suffering from severe asthma, including those without access to biologic therapies, those who were eligible but did not receive these treatments, and T2-targeted biologic recipients. The findings underscore the urgent need for improved healthcare resource utilization, increased access to biologics, and ongoing research on new treatment options to address the unmet needs of patients with severe asthma. Read the full press release: https://lnkd.in/g93bnptj Read the full article here: https://lnkd.in/gXYdYMS3 #ResearchInRealLife #SevereAsthma #Asthma #Research

The EVEREST study published in the Journal of Asthma and Allergy, “Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry”, has shed light on the significant global disease burden faced by patients suffering from severe asthma, including those without access to biologic therapies, those who were eligible but did not receive these treatments, and T2-targeted biologic recipients. The findings underscore the urgent need for improved healthcare resource utilization, increased access to biologics, and ongoing research on new treatment options to address the unmet needs of patients with severe asthma. Read the full press release: https://lnkd.in/g93bnptj Read the full article here: https://lnkd.in/gXYdYMS3 #ResearchInRealLife #SevereAsthma #Asthma #Research

Alzheimer's fascinating Allergy Connection September marks World Alzheimer's Month, a time to spotlight groundbreaking research connecting allergies to Alzheimer's. Although the month is over, you might be wondering what you can do to further your understanding and how you could help. Recent studies reveal intriguing differences in MMSE scores and CSF biomarkers among Alzheimer's patients with allergies. These findings open up new avenues for understanding the progression of this complex disease. For professionals in the healthcare and research fields, these insights could pave the way for innovative approaches to Alzheimer's care and treatment. Curious to delve deeper into these discoveries? View the link below for an opportunity at a free CE credit, as well as an in depth exploration of functional medicine's relationship with diseases like Alzheimer's. September may be over, but that doesn't mean our efforts to fighting Alzheimer's has to be. Together, we can make a difference. https://bit.ly/3Uj0H9y #webinar #CE #alzheimers

The 4th Davos Declaration: A Milestone for Atopic Dermatitis Patient Care ? During the last Global Allergy Forum (GAF) key opinion leaders from science, medicine and industry met in Davos to discuss the current state of the art of patient care in atopic dermatitis (AD) and proposed new strategies for its improvement. The thinktank addressed the high prevalence of AD and strategized methods to advance research, diagnostics, management and prevention. The findings are now published as “Navigating the Evolving Landscape of Atopic Dermatitis: Challenges and Future Opportunities: the 4th Davos Declaration”.

?? Today's update from EUFOREA: "Inadequate Rhinitis Control in Real Life - What to Do?". An article published in JACI IN PRACTICE (The Journal of Allergy and Clinical Immunology) under the leadership of Professor Glenis Scadding. This paper concludes that despite various guidelines, algorithms, and initiatives, managing persistent #rhinitis and #rhinosinusitis in Belgium is inadequately controlled among the most affected individuals. This issue is not limited to Belgium alone, and the actual situation may be more severe as those who declined to participate in the study (this study had participation of 1514 #patients) were probably not utilizing their medication properly. Open access here: https://lnkd.in/egWYvZcp

Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis. First author: Nan Wang; corresponding authors: Yin Yao, Zheng Liu Read the article here: doi.org/10.1111/all.16068 In allergic #rhinitis (AR) patients undergoing house dust mite subcutaneous immunotherapy (HDM SCIT), distinct clinical and immune features are observed between responders and nonresponders prior to treatment. A model with a combination of baseline sIgE/tIgE ratio, TFR/TFH2 cell ratio, and CD23+ BSM frequency exhibits a strong predictive value for SCIT efficacy, as evidenced by a 12-month posttreatment assessment. The efficacy of this model is validated in an independent cohort. #Allergy_journal Read more articles published in Allergy on #immunotherapy here: https://lnkd.in/dVsjXuR8 https://lnkd.in/gXSmW89Y is a link to the April issue table of contents.

Asthma showed ~30-48% greater Alzheimer risk. ?Studying associations between asthma and Alzheimer’s disease (AD) highlighted increased 2-year AD incidence (aOR, 1.33 [95% CI, 1.29-1.36]) & prevalence (aOR, 1.48 [95% CI, 1.47-1.50]) in asthma among 5 million US Medicare patients. https://lnkd.in/gyQZp7hu “Alzheimer incidence and prevalence with and without asthma: A?Medicare cohort study,” J of Allergy Clin Immunol, 2024 Christie Bartels, Yi Chen, W. Ryan Powell, M. Rosenkranz, B. Bendlin, J. Kramer, William Busse, Amy Kind